Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib

J Thorac Oncol. 2017 Sep;12(9):e141-e143. doi: 10.1016/j.jtho.2017.04.028.

Authors

Nobukazu Agatsuma¹, Yuto Yasuda², Hiroaki Ozasa³

Affiliations

¹ Department of Gastroenterology, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan.
² Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: yyasuda@kuhp.kyoto-u.ac.jp.
³ Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

PMID: 28838714
DOI: 10.1016/j.jtho.2017.04.028

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Afatinib / pharmacology
Afatinib / therapeutic use*
ErbB Receptors / genetics
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Male
Mesothelioma / drug therapy*
Mesothelioma / genetics*
Mesothelioma / pathology
Mesothelioma, Malignant
Middle Aged
Mutation

Substances

Afatinib
EGFR protein, human
ErbB Receptors